Packaging Update

HPS Pharmacies wish to advise that Phebra have updated the packaging and labelling on Laceraine® as follows:

Laceraine® Topical Wound Anaesthetic
Adrenaline (epinephrine) acid tartrate 9mg + Tetracaine (amethocaine) hydrochloride 25mg + Lidocaine (lignocaine) hydrochloride monohydrate 200mg in 5mL

The colour and design of the carton and vial label have been updated along with the information contained in the medicine label. Of particular importance is the change to the naming of the active ingredients in line with the Australian Approved Name.

Adrenaline is now labelled as ‘Adrenaline (Epinephrine) Acid Tartrate’. The conversion factor between this salt form and adrenaline is shown below:

9mg Adrenaline (Epinephrine) Acid Tartrate = 5mg Adrenaline

Please note: there has been no change to the formulation of this product.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Phebra on (02) 9420 9199.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates